InsidersTradesSigma
Follow the VERACYTE INC share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €3.6bn. The latest transaction was filed on 4 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: MARC STAPLEY. Every trade is free.
Analysts rate VERACYTE INC Buy (bullish), based on 11 analysts. Average price target: US$57.82.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Veracyte Inc 是一家分子诊断公司，提供检测以辅助医疗保健领域的临床决策。该公司在纳斯达克上市，股票代码为 VCYT。